-The Economic Times Successful implementation of the Food Security Bill will leave more savings in the hands of rural and urban below poverty line (BPL) households, enabling them to spend on health, education and nutritious food, a study said on Monday. The implementation of the Food Security Bill could also generate additional savings of around Rs 4,400 this year for every beneficiary household in some states, the report said. The savings would arise...

-Down to Earth Inadequate sewage treatment and disposal in the national capital territory is contaminating city's groundwater Delhi residents who depend on groundwater for their drinking water needs be warned. The latest data of the Central Ground Water Board (CGWB) shows that groundwater samples taken from observation wells in the national capital are getting contaminated because of their unhygienic catchments and untreated sewage, which is discharged in the open and into drains,...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...

-The Hindu     Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...